13 RUCAM is a seven part investigative method for predicting the likelihood of causation between drug use and liver injury using a point system based on the relation to time of liver injury onset after drug use, the course of liver enzyme changes, risk factors, concomitant drug use, evaluation of alternative causes for liver injury, previously known drug hepatotoxicity, and response to unintentional re-exposure
Generally, newer medications, such as GLP-1 agonists, are the least likely to be covered, while older drugs are commonly found on formularies
Per TeleHealth Med's published materials, the platform works with 503A State Board Regulated compound pharmacies
Why is DSIP supplied as a lyophilized powder
(PubMed) Onwude JL, Lilford RJ, Hjartardottir H, Staines A, Tuffnell D
Interestingly, the patients in the ATTAIN-MAINTAIN study were titrated up to the maximum tolerated dose (MTD) of either 24mg or 36mg once-daily, the top doses tested across Lillys Phase 3 trials with Orfoglipron